Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus
Cardiovascular (CV) morbidity and mortality are a challenge in management of patients with systemic lupus erythematosus (SLE). Higher risk of CV disease in SLE patients is mostly related to accelerated atherosclerosis. Nevertheless, high prevalence of traditional cardiovascular risk factors in SLE p...
Saved in:
| Main Authors: | Alberto Floris, Matteo Piga, Arduino Aleksander Mangoni, Alessandra Bortoluzzi, Gian Luca Erre, Alberto Cauli |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2018/3424136 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Protective Effects of Methotrexate against Proatherosclerotic Cytokines: A Review of the Evidence
by: Arduino A. Mangoni, et al.
Published: (2017-01-01) -
The role of anifrolumab in reshaping the treatment landscape of extra-renal systemic lupus erythematosus
by: Fulvia Ceccarelli, et al.
Published: (2025-07-01) -
Hydroxychloroquine in patients with systemic lupus erythematosus: how much is enough?
by: Guillermo Ruiz-Irastorza, et al.
Published: (2025-04-01) -
Correction: Hydroxychloroquine in patients with systemic lupus erythematosus: how much is enough?
Published: (2025-04-01) -
Successful treatment of cardiac tamponade with systemic lupus erythematosus using belimumab and hydroxychloroquine
by: Tomoo Kise, et al.
Published: (2023-01-01)